Literature DB >> 23891251

Successful endovascular treatment of a ruptured superior mesenteric artery in a patient with Ehlers‒Danlos syndrome.

Shota Yasuda1, Kiyotaka Imoto, Keiji Uchida, Daisuke Machida, Hiromasa Yanagi, Tadahisa Sugiura, Kenji Kurosawa, Munetaka Masuda.   

Abstract

The purpose of this study was to describe covered-stent treatment of a ruptured dissection of the superior mesenteric artery (SMA) in a patient with Ehlers‒Danlos syndrome. The patient was a 13-year-old girl initially presenting with abdominal pain. Dissection and rupture of the SMA were diagnosed on detailed examination. Conservative treatment was performed initially because open surgery was considered high risk. However, the abdominal pain recurred, and we decided to perform endovascular therapy. A coronary artery covered stent was placed in the true lumen to close the entry site of the dissection. The false lumen was obliterated using a post-dilation technique, completing treatment of the rupture. The patient recovered uneventfully after surgery. Classic-type Ehlers‒Danlos syndrome was diagnosed on the basis of physical findings and genetic analysis. The stent has remained adequately patent as of 2 years after surgery. This case report shows that dissection and rupture of the SMA can be treated successfully using a covered coronary artery stent in a patient with Ehlers‒Danlos syndrome.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23891251     DOI: 10.1016/j.avsg.2013.01.004

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  A Novel Recurrent COL5A1 Genetic Variant Is Associated With a Dysplasia-Associated Arterial Disease Exhibiting Dissections and Fibromuscular Dysplasia.

Authors:  Julie Richer; Hannah L Hill; Yu Wang; Min-Lee Yang; Kristina L Hunker; Jamie Lane; Susan Blackburn; Dawn M Coleman; Jonathan Eliason; Guillaume Sillon; Maria-Daniela D'Agostino; Prasad Jetty; François-Pierre Mongeon; Anne-Marie Laberge; Stephen E Ryan; Natalia Fendrikova-Mahlay; Thais Coutinho; Michael R Mathis; Matthew Zawistowski; Stanley L Hazen; Alexander E Katz; Heather L Gornik; Chad M Brummett; Goncalo Abecasis; Ingrid L Bergin; James C Stanley; Jun Z Li; Santhi K Ganesh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-17       Impact factor: 8.311

Review 2.  Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.

Authors:  Sanne D'hondt; Tim Van Damme; Fransiska Malfait
Journal:  Genet Med       Date:  2017-10-05       Impact factor: 8.822

3.  Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

Authors:  Marco Ritelli; Marina Venturini; Valeria Cinquina; Nicola Chiarelli; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2020-07-31       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.